REGN Regeneron Pharmaceuticals
$738.72 +1.69%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+1.69%
YTD
+26.70%
P/E
17.41
P/B
2.6
ROE
13.8%
Div yield
—
Beta
0.47
Market cap
$75.4B
RSI (14)
38
Next earnings
Oct 30, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$734.61
Close
$738.72
VWAP (n/a)
—
Day high
$740.51
Day low
$727.16
Volume
615K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Expanded Sanofi Alliance And New Pipeline Data Could Be A Game Changer For Regeneron (REGN)
Yahoo Finance · Oct 6
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
Yahoo Finance · Oct 6
Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets
Yahoo Finance · Oct 3
An $8 Billion Reason Why Regeneron Stock Is in Focus
Yahoo Finance · Oct 2
Sanofi, Regeneron Expand Immunology Alliance With New Antibodies
Yahoo Finance · Oct 2
Sanofi pays Regeneron up to $8B to expand immunology alliance
Yahoo Finance · Oct 2
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 6, 2026 View → 8-K Sep 30, 2026 View → 10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View → 8-K Jul 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell REGN. Try it in the Lab to size a position and see the risk.